Nonrulemaking

Requests that FDA declare that an ANDA may be submitted for, Cyproheptadine 2 mg, a strength that differs from the currently approved RLD, Cyproheptadine Hydrochloride tablets from HERITAGE PHARMA LABS INC, which FDA approved in 4 mg strength prior to Jan 1st, 1982, under ANDA #087056.

Documents
8
Total comments
0
all analyzed
Comment status
Open
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

📄 Primary document